Numerai’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Sell
15,450
-47
-0.3% -$5.11K 0.19% 179
2026
Q1
$1.43M Buy
15,497
+1,621
+12% +$163K 0.14% 225
2025
Q4
$1.42M Buy
+13,876
New +$1.24M 0.17% 188
2025
Q2
Sell
-7,709
Closed -$328K 528
2025
Q1
$328K Buy
+7,709
New +$333K 0.06% 365

Other funds holding GH

Numerai's GH Position: Q2 2026 in Review

Numerai reduced its Guardant Health (GH) stake by 0.3% in Q2 2026, selling an estimated $5.11K and leaving 15,450 shares worth $2.32M. The position accounts for 0.19% of the portfolio, ranked #179.

Numerai first reported a position in GH in Q1 2025 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Numerai held 15,450 shares of Guardant Health worth $2.32M as of Q2 2026.
  • Numerai sold 47 Guardant Health shares in Q2 2026, an estimated $5.11K.
  • Guardant Health made up 0.19% of Numerai's portfolio in Q2 2026, its #179 holding.
  • Numerai first reported a position in Guardant Health in Q1 2025 and has held it in 4 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.